Trial Profile
A comparative study of the safety, tolerability, and efficacy of cefdinir and cephalexin for the treatment of subjects with mild to moderate uncomplicated skin and skin structure infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Cefalexin (Primary) ; Cefdinir (Primary)
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 26 Oct 2007 Status changed from in progress to completed
- 26 Jun 2007 New trial record.